• Partners Group has completed a program valued at over $15 billion.
  • Criteria Caixa has sold its 2.64% stake in Cellnex for $660 million.
  • GSK has expressed satisfaction with the dismissal of a U.S. lawsuit related to Zantac, its heartburn medication.
  • Avolta, through its subsidiary HMSHost, has signed a 15-year contract at Sacramento airport.
  • Eli Lilly is expecting results from its Phase III trial of the experimental anti-obesity pill orforglipron in April 2025. Additionally, the FDA's expert panel has unanimously recommended donanemab, Eli Lilly's experimental Alzheimer's treatment. The company's shares rose 2.6% in pre-market trading following the FDA panel's endorsement.
  • Apple has launched a ChatGPT application on iPhone as part of its efforts to advance in AI and unveiled its AI news at its annual developer conference, including integrating "Apple Intelligence" into various apps and partnering with OpenAI. The stock saw a 0.4% decrease in pre-market trading.
  • Tesla is contending with allegations of false marketing in California over its Autopilot feature and must respond to charges by the California DMV. Moreover, CEO Elon Musk has stated he will ban Apple devices at his companies if Apple integrates OpenAI into its OS, citing security concerns.
  • Intel has put a halt to its plans for constructing a $25 billion factory in Israel.
  • Apollo Global Management and Kyndryl are reportedly in talks to acquire DXC Technology.
  • Liberty Strategic Capital (Steven Mnuchin) has announced a 7.7% stake in New York Community Bancorp.
  • El Al has confirmed the purchase of around thirty Boeing aircraft.
  • ARM Holdings and Qualcomm are embroiled in a legal battle that could impact the release of AI-enabled PCs.
  • Rogers Communications has entered into content agreements with NBCUniversal and Warner Bros. Discovery.
  • GameStop's stock has declined for the second consecutive day as the momentum from the meme stock rally diminishes.
  • Cosco Shipping Holdings saw its shares drop by over 8% in Hong Kong.
  • General Motors has announced a new $6 billion share buyback plan, following a recent dividend increase and positive annual forecast.
  • Rocket Lab has seen a 0.4% increase in pre-market trading after the announcement of a $23.9 million package from the U.S. Department of Commerce to expand the use of semiconductors in satellites and spacecraft.
  • Sage Therapeutics' stock rose 5.6% in pre-market trading after reporting that its experimental drug for Huntington's disease showed safety and some efficacy in trials.
  • Singapore Airlines will compensate passengers who experienced a turbulent flight.